After dealing with a deployment problem with glucose monitors earlier this year, interim CEO Jake Leach said improving ...

A proposed class of consumers has launched a lawsuit against Dexcom Inc., accusing the medical device maker of misleading advertising and dangerous product defects tied to its popular G7 Continuous ...

Abbott and Dexcom have agreed to settle all of their remaining international legal disputes over patents related to their continuous glucose monitors for people with diabetes—just weeks after a ...

DexCom has a well-established record of introducing the most precise sensors for use in its continuous glucose monitors. On the strength of its technology, DexCom has captured an impressive slice of ...

Beyond analysts' top-and-bottom-line estimates for DexCom (DXCM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ...

Although the revenue and EPS for DexCom (DXCM) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall ...